Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Anne Haegert
Affiliation
University of British Columbia
ORCID
Career Start Year
2008
Papers
35
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36181708
Indwelling stents cause obstruction and induce ureteral injury and fibrosis in a porcine model.
BJU Int
2023
37556934
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Gynecol Oncol
2023
36895072
Differentiation of Peritubular Myoid-Like Cells from Human Induced Pluripotent Stem Cells.
Adv Biol (Weinh)
2023
35082166
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.
Mol Cancer Res
2022
35816165
Isolating Nuclei From Frozen Human Heart Tissue for Single-Nucleus RNA Sequencing.
Curr Protoc
2022
33038264
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.
Int J Cancer
2021
33506972
Perivascular lymphocytic aggregates in hip prosthesis-associated adverse local tissue reactions demonstrate Th1 and Th2 activity and exhausted CD8<sup>+</sup> cell responses.
J Orthop Res
2021
34381166
Ketogenesis controls mitochondrial gene expression and rescues mitochondrial bioenergetics after cervical spinal cord injury in rats.
Sci Rep
2021
34192572
Cobalt ions induce metabolic stress in synovial fibroblasts and secretion of cytokines/chemokines that may be diagnostic markers for adverse local tissue reactions to hip implants.
Acta Biomater
2021
33945683
Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria.
ACS Appl Mater Interfaces
2021
33441310
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Cancer Res
2021
32512818
Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.
Cells
2020
29487201
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.
Cancer Res
2018
28330676
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
Eur Urol
2018
29544736
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Eur Urol
2018
27531099
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Bioinformatics
2017
28259916
Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.
Mol Med Rep
2017
28460430
Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.
Oncotarget
2017
28642484
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.
Sci Rep
2017
27663589
<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.
Clin Cancer Res
2017
27015368
The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
Oncotarget
2016
27148695
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.
JAMA Oncol
2016
25544761
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.
Oncotarget
2015
26235627
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Cell Rep
2015
26041878
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
Oncotarget
2015
25712683
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.
Clin Cancer Res
2015
24356420
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.
Cancer Res
2014
25155515
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
Genome Biol
2014
22294438
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
J Pathol
2012
22553170
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
J Pathol
2012
22615732
Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.
PLoS One
2012
22252602
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
Mol Cancer Ther
2012
19932600
Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray.
J Dermatol Sci
2010
19168852
Germline CDH1 deletions in hereditary diffuse gastric cancer families.
Hum Mol Genet
2009
18200053
Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
J Invest Dermatol
2008
1 - 35 of 35
Column Actions
Search
Recommended Authors
Rohan Bareja
Case Western Reserve University
Career Start Year
2017
Number of shared co-authors
9
Wei Yuan
The Institute for Cancer Research
Career Start Year
2015
Number of shared co-authors
9
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
9
Joshua Armenia
Oncology R&D
Career Start Year
2013
Number of shared co-authors
9
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year
2013
Number of shared co-authors
0
Sungyong You
Cedars-Sinai Medical Center
Career Start Year
2008
Number of shared co-authors
15
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year
2008
Number of shared co-authors
15
David A Quigley
University of California-San Francisco
Career Start Year
2008
Number of shared co-authors
23
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year
2007
Number of shared co-authors
10
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year
2006
Number of shared co-authors
5
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2005
Number of shared co-authors
1
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year
2005
Number of shared co-authors
27
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
2
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year
2003
Number of shared co-authors
8
Adam Foye
University of California San Francisco
Career Start Year
2003
Number of shared co-authors
18
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year
2003
Number of shared co-authors
30
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year
2001
Number of shared co-authors
8
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year
2001
Number of shared co-authors
24
Nadia Boufaied
Research Institute of the McGill University Health Centre
Career Start Year
2000
Number of shared co-authors
8
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
29
Hayley C Whitaker
University College London
Career Start Year
1999
Number of shared co-authors
5
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year
1999
Number of shared co-authors
17
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year
1999
Number of shared co-authors
10
Phillip G Febbo
Illumina Inc.
Career Start Year
1997
Number of shared co-authors
18
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year
1993
Number of shared co-authors
34
Suzanne Carreira
The Institute of Cancer Research
Career Start Year
1990
Number of shared co-authors
9
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1989
Number of shared co-authors
6
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
9
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
1988
Number of shared co-authors
18
Massimo Loda
Weill Medical College of Cornell University
Career Start Year
1984
Number of shared co-authors
24
row(s) 1 - 30 of 30
Collaborators
Colin C Collins
University of British Columbia
Co-authored papers
24
Robert H Bell
University of British Columbia
Co-authored papers
19
Yuzhuo Wang
University of British Columbia
Co-authored papers
18
Martin E Gleave
University of British Columbia
Co-authored papers
15
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers
15
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers
12
Stanislav V Volik
University of British Columbia
Co-authored papers
11
Sonal Brahmbhatt
University of British Columbia
Co-authored papers
10
Alexander W Wyatt
University of British Columbia
Co-authored papers
10
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers
9
Shawn Anderson
University of British Columbia
Co-authored papers
9
Ladan Fazli
University of British Columbia
Co-authored papers
9
Brian McConeghy
University of British Columbia
Co-authored papers
7
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers
6
Robert Shukin
University of British Columbia
Co-authored papers
5
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Amina Zoubeidi
University of British Columbia
Co-authored papers
5
Anna Lapuk
Contextual Genomics Inc.
Co-authored papers
4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers
4
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers
4
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers
4
Mark A Rubin
University of Bern
Co-authored papers
4
Faraz Hach
University of British Columbia
Co-authored papers
4
Raunak Shrestha
University of California San Francisco
Co-authored papers
3
Estelle Li
University of British Columbia
Co-authored papers
3
Andrew McPherson
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Christopher A Maher
Washington University in St Louis
Co-authored papers
3
Marco A Marra
University of British Columbia
Co-authored papers
3
Kim N Chi
University of British Columbia
Co-authored papers
3
Chunxiao Wu
Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers
3
1 - 30